3
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Hypothetical Integrative Medical Strategies for the Prevention and Treatment of Bio-terrorism Incidents

, , , &
Pages 301-319 | Published online: 13 Jul 2009

  • Centers for Disease Control Update. Investigation of anthrax associated with intentional exposure and interim public health guidelines. Centers for Disease Control and Prevention MMWR October 2001 ; 50: 889-97.
  • Jemigan JA, Stephens DS, Ashford DA, et al Bioterrorism-related inhalation anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001 ; 7(5): 1-26.
  • Inglesby TV et al. Anthrax as a biological weapon: medical and public health management (Consensus Statement). J Am Med Assoc 1999; 281: 1735-45.
  • Swartz MN. Recognition and management of anthrax--an update. N Engl J Med 2001 ; 345(22): 1621-6.
  • Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon. Medical and public health management. J Am Med Assoc 1999; 281: 2127-37.
  • Hanna PC, Kruskal BA, Ezkowitz RA, et al. Role of macrophage oxidative burst in the action of anthrax lethal toxin. Mol Med 1994; 1(1): 7-18.
  • Hanna PC. Understanding Bacillus anthracis pathogenicity. Trends Microbiol 1999; 7(5): 180-2.
  • Rea WJ. Chemical Sensitivity. Lewis Publishers: Boca Raton, 1992-1997.
  • Jacoby WB (ed.) Enzymatic Basis of Detoxication. Academic Piess: New York, 1980.
  • Scriver CR et al. (eds) The Metabolic and Molecular Basis of Inherited Disease, 8th edn. McGraw-HiIl: New York, 2000.
  • Latella G, Caprilli R. Metabolism of large bowel mucosa in health and disease. Int J Colored Dis 1991; 6: 127-32.
  • Galland L, Barrie S. Intestinal dysbiosis and the causes of disease. J Adv Med 1993; 6: 67-82.
  • Lichtman SN, Keku J, Schwab JH, Sartor RB. Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology 1991; 100(2): 513-9.
  • Kirsch M. Bacterial overgrowth. Am J Gastroent 1990; 85: 31-7.
  • Bjamason I et al. Intestinal permeability: an overview. Gastroenterology 1995; 108: 1566-81.
  • Shils ME et al Modern Nutrition in Health and Disease, 9th edn. Lippincott, Williams & Wilkins: Philadelphia, 1999.
  • Werbach MR, Moss J. Textbook of Nutritional Medicine. Third Line Press: Tarzana, CA, 1999.
  • Werbach MR. Foundations of Nutritional Medicine: a Sourcebook of Clinical Research. Third Line Press: Tarzana, CA, 1997.
  • Roitt IM, Brostoff J (eds). Immunology, 6th edn. C.V. Mosby: St Louis, MO, 2001.
  • Murray RK et al Harper's Biochemistry, 25th edn. McGraw-Hill: New York, 1999.
  • Suzuki T, Ohno N, Chiba N, Miura NN, Adachi Y, Yadomae T. Immunopharmacologica 1 activity of the purified insoluble glucan, zymocel, in mice. J Pharm Pharmacol 1996; 48(12): 1243-8.
  • Ooi VE, Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 2000; 7(7): 715-29.
  • Bogwald J, Johnson E, Seljelid R. The cytotoxic effect of mouse macrophages stimulated in vitro by a beta-1,3-D glucan from yeast cell walls. Scand J Immunol 1982; 14: 297-304.
  • Sandula J, Machova E, Hribalova V. Mitogenic activity of particulate yeast beta-1,3-D glucan and its water soluble derivatives. Int J Biol Macromol 1995; 17: 323-6.
  • Fullerton SA, Samadi AA, Tortorelis DG et al Induction of apoptosis in human prostatic cancer cells with beta-glucan (Maitake mushroom polysaccharide). Mol Urol 2000; 4(1): 7-13.
  • Pegel KH. The importance of sitosterol and sftosterolin in human and animal nutrition. S Afr J Sci 1997; 93: 263-8.
  • Bouic PJD, Etsebeth S, Liebenberg RW et al. Beta-sitosterol and beta-sitosterol glycoside stimulate human peripheral blood lymphocyte proliferation : implications for their use as an immunomodulatory vitamin combination. Int J Immunopharmacol 1996; 18: 693-700.
  • Bouic PJD. Plant sterols and sterolins: a review of their immune-modulating properties. Altern Med Rev 1999; 4: 170-7.
  • Bogden JD et al. Effects of one year of supplementatio n with zinc and other micronutrients on cellular immunity in the elderly. J Am Coll Nutr 1990; 9(3): 214-25.
  • Wagner PA et al Zinc nutritive and cell-mediated immunity in the aged. Int J Vitam Nutr Res 1983; 53(1): 94-101.
  • Duchateau J et al. Influence of oral zinc supplementation on the lymphocyte response to mitogens of normal subjects. Am J Clin Nutr 1981 ; 34: 88-93.
  • Chandra RJ. Nutrition and immunity in serious illness. Proc Nutr Soc 1993; 52: 77-84.
  • In Vivo Activities of Lactoferrin. NIH Guide, 1994; 23(14).
  • Zimecki M, Wlasczyk A. LF and its effects on the immune response. Arch Immunol Ther Exp (warsz) 1998; 46(4): 231-40.
  • Swart PJ, Kuipers EM. (LF and) Anti-viral activity against HIV and CMV in cell culture (flbroblasts). Adv Exp Med Biol 1998; 443: 205-13.
  • Ikeda M, Sugiyama K. (LF and) Prevention of Hep C in human liver cells in vitro. Biochem Biophys Res Commun 1998; 245(2): 549-53.
  • Zhang GH, Mann DM, Tsai CM. Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Infect Immun 1999; 67(3): 1353-8.
  • Lee WJ, Farmer JL, Hilty M, Kim YB. The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect Immun 1999; 66(4): 1421-6.
  • Yamauchi K, Wakabayashi H, Hashimoto S, Teraguchi S, Hayasawa H, Tomita M. Effects of orally administered bovine lactoferrin on the immune system of healthy volunteers. Adv Exp Med Biol 1998; 443: 261-5.
  • Dial EJ, Hall LR, Sema H, Romero JJ, Fox JG, Lichtenberger LM. Antibiotic properties of bovine lactoferrin on Helicobacter pylori. Dig Dis Sci 1998; 43(12): 2750-6.
  • Bhimani RS, Vendrov Y, Furmanski P. Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice. J Appl Microbiol 1999; 86(1): 135-44.
  • Vorland LH, Ulvatne H, Andersen J et al. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin. Scand J Infect Dis 1998; 30(5): 513-7.
  • Liang H et al. The effect of astragalus polysaccharides on cell mediated immunity (CMI) in burned mice. Chin J Plast Surg Bums 1994; 10(2): 138.
  • Rittenhouse JR et aL Chinese medicinal herbs reverse macrophage suppression induced by urological tumors. J Urol 1991; 146(2): 486.
  • Sun Y et al. Immune restoration and/or augmentation of local graft-versus-host reaction by traditional Chinese medicinal herbs. Cancer 1983; 52(1): 70-3.
  • Sun Y et al. Preliminary observations on the effects of the Chinese medicinal herbs Astragalus membranaceus and Ligustrum lucidum on lymphocyte blastogenic response. J Biol Respon Modif 1983; 2(3): 227-37.
  • Hou Y et al. Interferon induction and lymphocyte transformation stimulated by Astragalus membranaceus in mouse spleen cell cultures. Zhonghua Weisheng Wuxue Hemian Yixue Zazhi 1981 ; 1(2): 137-9.
  • Chen LJ, Shen ML, Wang MY, Zhai SK, Liu MZ. Effect of Astragalus polysaccharide s on phagocytic function in mice. Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao 1983; 5(4): 231-4 [in Chinese].
  • Chu DT, Lepe-Zuniga J, Wong WL, LaPushin R, Mavligit GM. Fractionated extract of Astragalus membranaceus, a Chinese medicinal herb, potentiates LAK cell cytotoxicity generated by a low dose of recombinant interleukin-2. Chung Kuo Yao Li Hsueh Pao 1981; 2(3): 200-4 [in Chinese].
  • Steinmuller C, Roesler J et al. Application of purified polysaccharide s from cell cultures of the plant Echinacea purpure a to mice mediates protection against systemic infection with Listeria monocyogenes and Candida albicans. Int J Immunopharmac 1991 ; 13: 27-37.
  • See DM, Broumand N, Sahl L, Tilles JG. In vitro effects of echinacea and ginseng on natural killer and antibody-dependen t cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology 1997; 35(3): 229-35.
  • Luettig B, Steinmüller C, Gifford GE, Wagner H, Lohmann-Matthes ML. Macrophage activation by the polysaccharide arabinogalacta n isolated from plant cell cultures of Echinacea purpure a, J Nail Cancer Inst 1989; 81(9): 669-75.
  • Spiegel D et al. Mind matters. Coping and cancer progression. J Psychosom Res 2001 ; 50(5): 287-90.
  • Schulman R. The Psychology of Chronic Illness. Basic Books/Harper Collins: New York, 1996.
  • Koenig HG et al. Handbook of Religion and Health: a Century of Research Reviewed. Oxford University Press: New York, 2000.
  • Dossey L. Healing Words: the Power of Prayer and the Practice of Medicine. Harper Collins: San Francisco, 1993.
  • Dossey L. Recovering the Soul: a Scientific and Spiritual Search. Bantam Books: New York, 1989.
  • Omish D. Love and Survival: the Scientific Basis for the Healing Power of Intimacy. Harper Collins: New York, 1998.
  • Larson DB. The Faith Factor, Vol. 2: An Annotated Bibliography of Systematic Reviews and Clinical Research on Spiritual Subjects. National Institute for Healthcare Research: Bethesda, MD, 1993.
  • Pannifer AD et al. Crystal structure of the anthrax lethal factor. Nature 2001 ; October.
  • Bradley KA et al. Identification of the cellular receptor for anthrax toxin. Nature 2001; October.
  • Mourez M et al. Designing a polyvalent inhibitor of anthrax toxin. Nature Biotechnology 2001 ; 19: 958-61.
  • Shin S et al. Dehydroepiandrosteron e and melatonin prevent Bacillus anthracis lethal toxin-induced TNF production in macrophages. Cell Biol Toxicol 2000; 16: 165-74.
  • Rahman I. Inflammation and the regulation of glutathione level in lung epithelial cells. Antioid Redox Signal 1999; 1(4): 425-47.
  • Rahman Q. Glutathione redox system in oxidative lung injury. Crit Rev Toxicol 1999; 29(6): 543-68.
  • Borok Z. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 1991; 338: 215-6.
  • Holroyd K et al. Correction of glutathione deficiency in the lower respiratory tract of HIV seropositive individuals by glutathione aerosol treatment. Thorax 1993; 48: 985-9.
  • Lamson DW, Brignall MS. The use of nebulized glutathione in the treatment of emphysema: a case report. Altern Med Rev 2000; 5(5): 429-31.
  • MacNee W. Oxidants and antioxidants as therapeutic targets in COPD. Am J Respir Crit Care Med 1999; 160: 558-65.
  • Marrades RM et al. Nebulized glutathione induces bronchcoconstrictio n in patients with mild asthma. Am J Respir Crit Care Med 1997; 156(2): 425-30.
  • Snashall PD, Baldwin C. Mechanisms of sulfur dioxide induced bronchoconstrictio n in normal and asthmatic men. Thorax 1982; 37: 118-23.
  • Lewis RR et al. Leukotrienes and other products of the 5-lipoxygenas e pathway. N Engl J Med 1990; 323: 645-55.
  • Jones AL. Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review. J Toxicol Clin Toxicol 1998; 36(4): 277-85.
  • DeMattia G, Bravi MC, Laurenti O, et al. Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes. Diabetologia Nov 1998:41(11): 1392-6.
  • Pelle E, Ingrassia M, Mammone T, et al. Protection against cigarette smoke-induced damage to intact transformed rabbit corneal cells by N-acetyl-L-cysteine. Cell Biol Toxicol Aug 1998; 14(4): 253-9.
  • Bernard GR. N-acetylcysteine in experimental and clinical acute lung injury. Am J Med 1991; 91(3C): 545-95.
  • Thies JC, Teklote J, Clauer U, et al The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation. Transpl Int 1998; 11(Suppl. 1): S390-2.
  • Roederer M et aL Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci 1990; 87: 4884-8.
  • Robinson MK et al. Glutathione deficiency and HIV infection. Lancet 1992; 339: 1603-4.
  • De Flora S et al. Attenuation of influenza like symptomatology and improvement of cell mediated immunity with long-term N-acetylcysteine treatment. Bur Respir J 1997; 10: 1535-41.
  • International Programme on Chemical Safety; Poisons Information Monograph 396: Paracetamol. Medical Toxicology Unit, Guy's and St Thomas's Trust: London, 1996.
  • Smith AR, Visioli F, Hagen TM. Vitamin C matters: increased oxidative stress in cultured human aortic endothelial cells without supplemental ascorbic acid. FASEB J 2002; 16(9): 1102-4.
  • Jenner AM, Ruiz JE, Dunster C, Halliwell B, Mann GE, Siow RC. Vitamin C protects against hypochlorous acid-induced ghitathione depletion and DNA base and protein damage in human vascular smooth muscle cells. Arterioscler Thromb Vase Biol 2002; 22(4): 574-80.
  • Tauler P, Aguilo A, Fuentespina E, Tur JA, Pons A. Diet supplementation with vitamin E, vitamin C and beta-carotene cocktail enhances basal neutrophil antioxidant enzymes in athletes. Pflugers Arch 2002; 443(5-6): 791-7.
  • Guaiquil VH, Vera JC, Golde DW. Mechanism of vitamin C inhibition of cell death induced by oxidative stress in glutathione-deplete d HL-60 cells. J Biol Chem 2001 ; 276(44): 40955-61.
  • May JM, Qu Z, Li X. Requirement for GSH in recycling of ascorbic acid in endothelial cells. Biochem Pharmacol 2001; 62(7): 873-81.
  • Nardini M, Finkelstein EI, Reddy S et al. Acrolein-induced cytotoxicity in cultured human bronchial epithelial cells. Modulation by alpha-tocophero 1 and ascorbic acid. Toxicology 2002; 170(3): 173-85.
  • De Ia Fuente M, Victor VM. Ascorbic acid and N-acetylcysteine improve in vitro the function of lymphocytes from mice with endotoxin-induced oxidative stress. Free Radie Res 2001 ; 35(1): 73-84.
  • Victor W, Guayerbas N, Puerto M, Medina S, De Ia Fuente M. Ascorbic acid modulates in vitro the function of macrophages from mice with endotoxic shock. Immunopharmacology 2000; 46(1): 89-101.
  • Cadenas S, Rojas C, Barja G. Endotoxin increases oxidative injury to proteins in guinea pig liver: protection by dietary vitamin C. Pharmacol Toxicol 1998; 82(1): 11-18.
  • Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Radie Biol Med 1995; 19: 227-50.
  • Tirosh O, Sen CK, Roy S et al. Neuroprotective effects of alpha-lipoic acid and its positively charged amide analogue. Free Radie Biol Med (United States) 1999; 26(11-12): 1418-26.
  • Becker RO. The effect of electrically generated silver ions on human cells. First International Conference on Gold and Silver in Medicine, Bethesda, MD, 13-14 May 1987.
  • Eichhorn GL, Shin YA, Butzow JJ, Clark P, Tarien E. Interaction of metal ions with biological systems, with special reference to silver and gold. First International Conference on Gold and Silver in Medicine, Bethesda, MD, 13-14 May 1987.
  • Flick AB. Clinical application of electrical silver iontophoresis. First International Conference on Gold and Silver in Medicine, Bethesda, MD, 13-14 May 1987.
  • Lee JV, Hibberd ML, Stanley SC. A Comparison of the Biocidal Properties of Silver Ions and Chloride against Legionella Species; PHLS Centre for Applied Microbiology and Research: Porton Down, DD3/2 AGREPORT, 1989.
  • Thurman RB, Gerba CP. The molecular mechanisms of copper and silver ion disinfection of bacteria and viruses. CRC Crit Rev Environ Control 1989; 18(4).
  • Henderson DA et al. Smallpox as a biological weapon (Consensus Statement). J Am Med Assoc 1999; 281(22): 2127-37.
  • Fauci AS et al. Harrison's Principles of Internal Medicine, 14th edn. McGraw-Hill: New York, 1998.
  • De Clercq E et al. Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvims infections. Clin Microbiol Rev 2001; 14(2): 382-97.
  • Taylor EW. Selenium and viral diseases: facts and hypotheses. J Orthomol Med 1997; 12-1: 227-39.
  • Taylor EW, Ramanathan CS, Jalluri RK, Nadimpalli RG. A basis for new approaches to the chemotherapy of AIDS: novel genes in HIV-I potentially encode selenoproteins expressed by ribosomal frameshifting and termination suppression. J Med Chem 1994; 37: 2637-54.
  • Beck MA, Shi Q, Morris VC, Levander OA. Rapid genomic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nature Med 1995; 1:433-6.
  • Taylor EW, Ramanathan CS, Nadimpalli RG, Schinazi RF. Do some viruses encode selenoproteins ? Assessment of the theory in the light of current theoretical, experimental and clinical data. Antiviral Res 1995; 26: A271,#86.
  • Yu SY, Li WG, Zhu YJ et al. Chemopievention trial of human hepatitis with selenium supplementation in China. Biol Trace Element Res 1989; 20: 15-22.
  • Beck MA, Kolbeck PC, Rohr LH et al. Benign human enterovirus becomes virulent in seleniumdeficient mice. J Med Virol 1994; 43: 166-70.
  • [Ill] Taylor EW, Ramanathan CS. Theoretical evidence that the Ebola virus Zaire strain may be selenium dependent: a factor in pathogenesis and viral outbreaks? J Orthomol Med 1995; 10: 131-8.
  • Ramanathan CS, Taylor EW. Computational genomic analysis of hemorrhagic fever viruses: viral selenoproteins as a potential factor in pathogenesis. Biol Trace Element Res 1997; 56: 93-106.
  • Hou JC. Inhibitory effect of selenite and other antioxidants on complement-mediated tissue injury in patients with epidemic hemorrhagic fever. Biol Trace Element Res 1997; 56: 125-30.
  • Senkevich TG, Bugert JJ, Sisler JR et al. Genome sequence of a human tumorigenic pox virus: prediction of specific host response-evasion genes. Science 1996; 273: 813-16.
  • Cowgill UM. The distribution of selenium and mortality owing to acquired immune deficiency syndrome in the continental United States. Biol Trace Element Res 1997; 56: 43-61.
  • Renis HE. In vitro anti viral activity of calcium elenolate. Antimicrob Agents Chemother 1969; 9: 167-72.
  • Fleming H, Walter W et al. Antimicrobial properties of oleuropein and products of its hydrolysis from green olives. Microbiology 1973; 26(5): 777-82.
  • Renis HE. Inactivation of myxoviruses by calcium elenolate. Antimicrob Agents Chemother 1975; 8(2): 194-9.
  • Heinze J, Hale AH, Carl P. Specificity of the anti viral agent calcium elenolate. Antimicrob Agents Chemother 1975; 8(4): 421-5.
  • Kaij-a-Kamb M, Amoros M, Girre L. Search for new antiviral agents of plant origin. Pharma-Acta-HeIv 1992; 67(5-6): 130-47.
  • Visioli F, Bellosta S, Galli C. Oleuropein, the bitter principle of olives, enhances nitric oxide production by mouse macrophages. Life Sei 1998; 62(6): 541-6.
  • Ma SC, He ZD, Deng XL et al. In vitro evaluation of secoiridoid glucosides from the fruits of Ligustrum lucidum as antiviral agents. Chem Pharm Bull (Tokyo) 2001 ; 49(11): 1471-3.
  • Walker M. Antimicrobial attributes of olive leaf extract. Townsend Letter for Doctors and Patients 1996; July: 80-5, #156.
  • Kabara JJ, Swieczkowski DM, Conley AJ, Truant JP. Fatty acids and derivatives as antimicrobial agents. Antimicrob Agents Chemother 1972; 2(1): 23-8.
  • Conley AJ, Kabara JJ. Antimicrobial action of esters of polyhydric alcohols. Antimicrob Agents Chemother 1973; 4: 501-6.
  • Kabara JJ, Vrable R, Lie Ken Jie MSF. Antimicrobial lipids: natural and synthetic fatty acids and monoglycerides. Lipids 1977; 12: 753-9.
  • Kabara JJ. Lipids as host resistance factors of human milk. Nutr Rev 1980; 38: 65-73.
  • Kabara JJ. Medium-chain fatty acids and esters as antimicrobial agents. In: Kabara JJ (ed.) Cosmetic and Drug Presentation: Principles and Practice. Marcel Dekker: New York, 1984.
  • Hierholzer JC, Kabara JJ. In vitro effects of monolaurin compounds on enveloped RNA and DNA viruses. J Food Safety 1982; 4: 1-12.
  • Kabara JJ, Ohkawa M, Dcekawa T, Katori T, Nishikawa Y. Examinations on antitumor immunological, and plant-growth inhibitory effects of monoglycerides of caprylic, capric, and lauric acids and related compounds. In: Kabara JJ (ed.) The Pharmacological Effect of Lipids II. American Oil Chemists' Society: Champaign, IL, 1985.
  • Floumoy DJ, Kabara JJ. The role of lauricidin® as an antimicrobial agent. Drugs of Today 1985; 21(8): 373-7.
  • Crouch AA, Seow WK, Whitman LM, Thong YH. Effect of human milk and infant milk formulae on adherence of Giardia intestinalis. Trans R Soc Trop Med Hyg 1991; 85: 617-19.
  • Dodge JA, Sagher FA. Antiviral and antibacterial lipids in human milk and infant formula. Arch Dis Child 1991 ; 66: 272-3.
  • Enig MG. Lauric oils as antimicrobial agents: theory of effect, scientific rationale, and dietary applications as adjunct nutritional support for HTV-infected individuals. In: Watson RR (ed.) Nutrients and Foods in AIDS. CRC Press: Boca Raton, 1998.
  • Epstein SE, Speir E, Zhou YF, Guetta E, Leon M, Pinkel T. The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus. Lancet 1996; 348(Suppl. 1): S13-17.
  • Isaacs CE, Thormar H. Membrane-disruptiv e effect of human milk: inactivation of enveloped viruses. J Infect Dis 1986; 154: 966-71.
  • Isaacs CE, Schneidman K. Enveloped viruses in human and bovine milk are inactivated by added fatty acids (FAs) and monoglycerides (MGs). FASEB J 1991 ; 5: A1288 (Abstract 5325).
  • Witcher KJ, Novick RP, Schlievert PM. Modulation of immune cell proliferation by glycerol monolaurate. Clin Diag Lab Immunol 1996; 3: 10-13.
  • van Rossum TG, Vulto AG, de Man RA, Brouwer JT, Schalm SW. Review article: Glycyrrhizin as a potential treatment for chronic hepatitis C. Department of Hepatogastroenterology, Erasmus University Hospital: Rotterdam (PubMed; PMDD: 9570253).
  • Shibayama Y. Prevention of hepatotoxic responses to chemicals by glycyrrhizin in rats. Exp Mol Pathol 1989; 51(1): 48-55.
  • Vithoulkas G. Science of Homeopathy. ASOHM: Athens, 1978.
  • Jonas WB. Do homeopathic nosodes protect against infection? Altern Ther Health Med 1999; 5(5): 36-40.
  • Sankaran P. Prophylactics in homeopathy. Elements of Homeopathy. Homeopathic Medical Publishers: Bombay. (Originally published in British Journal of Homeopathy, c. 1960.)
  • VanDenBerghe S. Anthracinum in splenic fever. Br J Homeop 1911 ; 460-5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.